ANAB   $22.25  5.10% Market Closed After Close 22.27 0.09%

AnaptysBio Inc
Total Cash 430.12M
totalCashPerShare 14.135
EBITDA -139.45M
Total Debt 367.06M
quickRatio 10.08
currentRatio 10.225
Total Revenue 57.17M
debtToEquity 435.073
Revenue/Share 2.086
ROA -0.17853001
ROE -1.61815
grossProfits
freeCashflow -74.90M
operatingCashflow -103.01M
earningsGrowth
revenueGrowth 8.047
grossMargins -1.3137699
ebitdaMargins -2.43911
operatingMargins -0.75814
profitMargins -2.89754
enterpriseValue 541.87M
forwardPE -3.295252
floatShares 19.85M
sharesOutstanding 30.20M
sharesShort 5.98M
sharesShortPriorMonth 5.83M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.02%
Short Ratio help_outline 20.13%
shortPercentOfFloat 0.27%
impliedSharesOutstanding
bookValue 2.773
Price To Book help_outline 8.01
earningsQuarterlyGrowth
netIncomeToCommon -165.66M
trailingEps -6.35%
forwardEps -6.74%
enterpriseToEbitda -3.89
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.63 4Q 2024
institutionsCount 204
lastUpdated Nov. 7, 2024, 2:34 a.m.